Item request has been placed!

Item request cannot be made.

Processing Request

نتائج البحث

Display Settings

النتائج لكل صفحة: 10

Sort By: Relevance

Filter

فلترة النتائج

Collection : Sciencedirect (Elsevier - Open Access Articles Via Crossref)

إعادة تعيين خيارات الفبترة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Iron Chelation with Deferasirox Suppresses the Appearance of Labile Plasma Iron During Conditioning Chemotherapy Prior to Allogeneic Stem Cell Transplantation

Authors : Essmann, Sonja; Heestermans, Marco; Dadkhah, Adrin

Source: Transplantation and Cellular Therapy ; volume 29, issue 1, page 42.e1-42.e6 ; ISSN 2666-6367

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

POLIMORFISMOS GENÉTICOS E NÍVEIS DE FERRITINA EM PACIENTES COM ANEMIA FALCIFORME EM USO DE DEFERASIROX

Authors : Almeida, ACV; Dinardo, C; Ozahata, MC

Source: Hematology, Transfusion and Cell Therapy ; volume 45, page S10-S11 ; ISSN 2531-1379

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Duodenal perforation caused by deferasirox “case report”

Authors : Al Blooshi, Mohammmed; Hamchou, Mustafa; AlSalem, Ahmed

Source: Journal of Pediatric Surgery Case Reports ; volume 94, page 102653 ; ISSN 2213-5766

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Kinetic aspects of iron(III)-chelation therapy with deferasirox (DFX) revealed by the solvolytic dissociation rate of the Fe(III)–DFX complex estimated with capillary electrophoretic reactor

Authors : Suzuki, Ryota; Iki, Nobuhiko

Source: Journal of Inorganic Biochemistry ; volume 241, page 112131 ; ISSN 0162-0134

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Iron chelator deferasirox inhibits NF-κB activity in hepatoma cells and changes sorafenib-induced programmed cell deaths

Authors : Jomen, Wataru; Ohtake, Takaaki; Akita, Takayuki

Source: Biomedicine & Pharmacotherapy ; volume 153, page 113363 ; ISSN 0753-3322

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

EE148 Canadian Cost-Effectiveness Analysis of Deferiprone Compared to Deferoxamine and Deferasirox for the Treatment of Iron Overload in Patients With Sickle Cell Disease and Other Anemias

Authors : Azimpour, K; Ramjee, L; Tremblay, G

Source: Value in Health ; volume 25, issue 12, page S82 ; ISSN 1098-3015

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Iron Chelation With Deferasirox Increases Busulfan AUC During Conditioning Chemotherapy Prior to Allogeneic Stem Cell Transplantation

Authors : Essmann, Sonja; Dadkhah, Adrin; Janson, Dietlinde

Source: Transplantation and Cellular Therapy ; volume 28, issue 2, page 115.e1-115.e5 ; ISSN 2666-6367

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Comparative efficacy and safety of once daily dosing and twice daily dosing of deferasirox in reducing serum ferritin levels in children with thalassemia major

Authors : Dar, Mohammad Irfan; Bhat, Vidushi

Source: Pediatric Hematology Oncology Journal ; volume 6, issue 4, page S40 ; ISSN 2468-1245

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

Moxibustion with deferasirox results in safe, accelerated, and sustained cardiac iron chelation for a young Diamond Blackfan Anemia patient: An integrative case report

Authors : Marie, Erika Fayina

Source: EXPLORE ; volume 17, issue 3, page 239-246 ; ISSN 1550-8307

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

Academic Journal

PIH17 Efficacy, Tolerability And Medication Adherence Of Twice-Daily Dosing Schedule Of Deferasirox In Transfusion-Dependent Paediatric Beta-Thalassemia Patients: A Randomized Controlled Study

Authors : Sebastian, J.; Babu, T.; Panachiyil, G.M.

Source: Value in Health Regional Issues ; volume 22, page S47 ; ISSN 2212-1099

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Iron Chelation with Deferasirox Suppresses the Appearance of Labile Plasma Iron During Conditioning Chemotherapy Prior to Allogeneic Stem Cell Transplantation

POLIMORFISMOS GENÉTICOS E NÍVEIS DE FERRITINA EM PACIENTES COM ANEMIA FALCIFORME EM USO DE DEFERASIROX

Duodenal perforation caused by deferasirox “case report”

Kinetic aspects of iron(III)-chelation therapy with deferasirox (DFX) revealed by the solvolytic dissociation rate of the Fe(III)–DFX complex estimated with capillary electrophoretic reactor

Iron chelator deferasirox inhibits NF-κB activity in hepatoma cells and changes sorafenib-induced programmed cell deaths

EE148 Canadian Cost-Effectiveness Analysis of Deferiprone Compared to Deferoxamine and Deferasirox for the Treatment of Iron Overload in Patients With Sickle Cell Disease and Other Anemias

Iron Chelation With Deferasirox Increases Busulfan AUC During Conditioning Chemotherapy Prior to Allogeneic Stem Cell Transplantation

Comparative efficacy and safety of once daily dosing and twice daily dosing of deferasirox in reducing serum ferritin levels in children with thalassemia major

Moxibustion with deferasirox results in safe, accelerated, and sustained cardiac iron chelation for a young Diamond Blackfan Anemia patient: An integrative case report

PIH17 Efficacy, Tolerability And Medication Adherence Of Twice-Daily Dosing Schedule Of Deferasirox In Transfusion-Dependent Paediatric Beta-Thalassemia Patients: A Randomized Controlled Study

اتصل بنا

اتبع